Bringing new medicines to patients with unmet medical need is built on collaborations between healthcare professionals and the pharmaceutical industry.
To improve health outcome the industry is dependent on the invaluable work done by practitioners to improve both care and treatment options. A healthy transparent working relationship between the industry and healthcare professionals/organisations is relying on transparency when it comes to disclosure of payments made to healthcare professionals.
Immedica will on this page when applicable disclose payments for attendance, sponsorships, speaker fees and other consultancy fees. In some countries the authority’s has local databases where it is mandatory to disclose the above and Immedica will follow local regulations.